Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Retained Earnings (2020 - 2025)

Historic Retained Earnings for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$293.0 million.

  • Barinthus Biotherapeutics' Retained Earnings fell 3494.69% to -$293.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.0 million, marking a year-over-year decrease of 3494.69%. This contributed to the annual value of -$237.7 million for FY2024, which is 3458.52% down from last year.
  • As of Q3 2025, Barinthus Biotherapeutics' Retained Earnings stood at -$293.0 million, which was down 3494.69% from -$278.4 million recorded in Q2 2025.
  • Barinthus Biotherapeutics' 5-year Retained Earnings high stood at -$73.0 million for Q1 2021, and its period low was -$293.0 million during Q3 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' median Retained Earnings value was -$145.2 million (recorded in 2023), while the average stood at -$159.6 million.
  • Per our database at Business Quant, Barinthus Biotherapeutics' Retained Earnings skyrocketed by 1221.54% in 2022 and then tumbled by 9414.04% in 2023.
  • Barinthus Biotherapeutics' Retained Earnings (Quarter) stood at -$108.6 million in 2021, then rose by 4.92% to -$103.2 million in 2022, then tumbled by 71.04% to -$176.6 million in 2023, then plummeted by 34.59% to -$237.7 million in 2024, then dropped by 23.28% to -$293.0 million in 2025.
  • Its Retained Earnings stands at -$293.0 million for Q3 2025, versus -$278.4 million for Q2 2025 and -$257.3 million for Q1 2025.